DK0966532T3 - Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette - Google Patents

Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette

Info

Publication number
DK0966532T3
DK0966532T3 DK98903075T DK98903075T DK0966532T3 DK 0966532 T3 DK0966532 T3 DK 0966532T3 DK 98903075 T DK98903075 T DK 98903075T DK 98903075 T DK98903075 T DK 98903075T DK 0966532 T3 DK0966532 T3 DK 0966532T3
Authority
DK
Denmark
Prior art keywords
mammal
biological material
nucleic acid
acid sequence
gene
Prior art date
Application number
DK98903075T
Other languages
Danish (da)
English (en)
Inventor
Marc Piechaczyk
Daniele Noel
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of DK0966532T3 publication Critical patent/DK0966532T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK98903075T 1997-01-20 1998-01-16 Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette DK0966532T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9700540A FR2758569B1 (fr) 1997-01-20 1997-01-20 Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le concernant
PCT/FR1998/000081 WO1998031808A1 (fr) 1997-01-20 1998-01-16 Materiel biologique pour le traitement d'un mammifere par transfert de gene d'anticorps et composition pharmaceutique le contenant

Publications (1)

Publication Number Publication Date
DK0966532T3 true DK0966532T3 (da) 2007-07-30

Family

ID=26233268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98903075T DK0966532T3 (da) 1997-01-20 1998-01-16 Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette

Country Status (8)

Country Link
EP (1) EP0966532B1 (de)
AT (1) ATE357520T1 (de)
DE (1) DE69837380T2 (de)
DK (1) DK0966532T3 (de)
ES (1) ES2285755T3 (de)
FR (1) FR2758569B1 (de)
PT (1) PT966532E (de)
WO (1) WO1998031808A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
FR2784997A1 (fr) * 1998-10-22 2000-04-28 Transgene Sa Materiel biologique pour la preparation de compositions pharmaceutiques destinees au traitement de mammiferes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0456640A1 (de) * 1988-12-13 1991-11-21 UNITED STATES GOVERNMENT as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Genetisch erzeugte endothelzellen und deren verwendung
FR2706486B1 (fr) * 1993-06-16 1995-09-01 Rhone Poulenc Rorer Sa Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.

Also Published As

Publication number Publication date
FR2758569B1 (fr) 1999-04-02
ATE357520T1 (de) 2007-04-15
ES2285755T3 (es) 2007-11-16
FR2758569A1 (fr) 1998-07-24
EP0966532A1 (de) 1999-12-29
PT966532E (pt) 2007-06-29
DE69837380D1 (de) 2007-05-03
DE69837380T2 (de) 2007-11-29
WO1998031808A1 (fr) 1998-07-23
EP0966532B1 (de) 2007-03-21

Similar Documents

Publication Publication Date Title
RU2207878C2 (ru) "очеловеченные" антитела против gp39 человека, композиции, содержащие эти антитела, и их терапевтическое использование
FR19C1020I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
FI820075L (fi) Rekombination-dna-medel och foerfarande
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
LU91237I2 (fr) Palifermin et ses dérivés pharmaceutiquement acceptables (kepivance)
ZA958444B (en) Biological active proteins
WO2000006705A3 (de) Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie
ES2115662T3 (es) Modificacion genetica de celulas endoteliales.
ATE338816T1 (de) Verfahren zur herstellung rekombinanterpolyklonaler proteine
DE68925226T2 (de) Monoklonale Antikörper
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
DK0966532T3 (da) Biologisk materiale til behandling af et pattedyr ved antistofgenoverföring og farmaceutisk præparat indeholdende dette
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
EP1344821A4 (de) Neue aggrecanase
DK1084246T3 (da) Biologisk materiale til fremstilling af farmaceutiske præparater til behandling af pattedyr
EP0727490A4 (de) Prostacyclinsynthase aus mensch
Dreesen et al. A peptide-reactive antibody to a Balbiani ring gene product: immunological evidence that a 6.5-kb RNA in Chironomus tentans salivary glands is mRNA for a 180-kDa nonfibrous component of larval secretion
WO2002088375A3 (en) Compositions and methods relating to breast specific genes and proteins
ATE419350T1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc- 2
NO20012214L (no) Fremstilling av en biologisk faktor og frembringelse av et immunologisk fordelaktig miljö ved anvendelse av genetiskforandrede Sertoliceller
FR2603040A1 (fr) Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose
DE60234047D1 (de) 15603, ein mitglied der humanen ionenkanal-familie
WO2002042460A3 (en) Compositions and methods relating to colon specific genes and proteins
WO2001075098A3 (en) 33166, a human hydrolase-like molecule and uses thereof